Evidence map›Paper›PMID 38456048›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2024

Crystal structure and Hirshfeld surface analysis of 3-phenyl-1-{3-[(3-phenyl-quinoxalin-2-yl)-oxy]prop-yl}-1,2-di-hydro-quinoxalin-2-one.

Nadeem Abad, Joel T Mague, Abdulsalam Alsubari, El Mokhtar Essassi, Abdullah Yahya Abdullah Alzahrani, Youssef Ramli

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Synthesis, crystal structure and Hirshfeld surface analysis of 2-phenyl-3-(prop-2-yn-1-yl-oxy)quin-oxaline.Acta crystallographica. Section E, Crystallographic communications · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nadeem AbadLaboratory of Medicinal Chemistry, Drug Sciences Research Center, Faculty of Medicine and Pharmacy Mohammed V University in Rabat, Morocco.
Joel T MagueDepartment of Chemistry, Tulane University, New Orleans, LA 70118, USA.ORCID https://orcid.org/0000-0003-3488-1945
Abdulsalam AlsubariLaboratory of Medicinal Chemistry, Faculty of Clinical Pharmacy, 21 September University, Yemen.
El Mokhtar EssassiLaboratory of Heterocyclic Organic Chemistry Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Abdullah Yahya Abdullah AlzahraniDepartment of Chemistry, Faculty of Science and Arts, King Khalid University, Mohail, Assir, Saudi Arabia.
Youssef RamliLaboratory of Medicinal Chemistry, Drug Sciences Research Center, Faculty of Medicine and Pharmacy Mohammed V University in Rabat, Morocco.ORCID https://orcid.org/0000-0002-6885-5692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the title compound, C

Indexed as

alkyl­ationcrystal structureHirshfeld surface analysishydrogen bondquinoxalineπ-stacking

Identifiers

PMID38456048
PMCPMC10915666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.